Porta C, Moroni M, Ferrari S, Nastasi G
Department of Internal Medicine and Medical Therapy, University of Pavia, Italy.
Neoplasma. 1998;45(2):81-2.
Cardiotoxicity is an uncommon side-effect of 5-FU-based chemotherapy. Coronary artery vasospasms have been postulated to be involved in the pathogenesis of this rare but serious problem. We found high plasma levels of ET-1, a potent natural vasoconstrictor, in two patients who experienced two of the commonest clinical manifestations of 5-FU-induced cardiac toxicity--i.e., angina pectoris and chronic heart failure. We, therefore, propose ET-1 as the ultimate mediator of this toxicity, even though the mechanism of ET-1 increase in peripheral venous blood is still unknown. Finally, another important question still remains unresolved: is the release of ET-1 from normal coronary endothelial cells the prime cause or simply the consequence of 5-FU-related cardiotoxicity?
心脏毒性是基于5-氟尿嘧啶化疗的一种罕见副作用。冠状动脉血管痉挛被认为与这个罕见但严重问题的发病机制有关。我们在两名经历了5-氟尿嘧啶诱导的心脏毒性最常见的两种临床表现(即心绞痛和慢性心力衰竭)的患者中发现血浆中强效天然血管收缩剂内皮素-1(ET-1)水平很高。因此,我们提出ET-1是这种毒性的最终介质,尽管外周静脉血中ET-1升高的机制仍然未知。最后,另一个重要问题仍未解决:正常冠状动脉内皮细胞释放ET-1是5-氟尿嘧啶相关心脏毒性的主要原因还是仅仅是其结果?